SCHEMBL13633838

SCHEMBL13633838

Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(-n3c(C)nc4ccc(SOON)cc4c3=O)cc2)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.41
PPARG P37231 1/20 0.39
TP53 P04637 3/20 0.39
NOD1 Q9Y239 1/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
MAPT P10636 4/20 0.36
ATM Q13315 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 2/20 0.35
HPD P32754 4/20 0.35
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12161424 0.92 P2RY12 (0.50) P2RY12PPARGTP53NOD1CA12
SCHEMBL12161429 0.85 P2RY12 (0.51) P2RY12PPARGTP53NOD1CA12
SCHEMBL9922358 0.84 P2RY12 (0.45) P2RY12PPARGTP53NOD1MAPT
SCHEMBL12161482 0.83 P2RY12 (0.40) P2RY12PPARGMAPTLMNA
SCHEMBL12161459 0.82 P2RY12 (0.46) P2RY12NOD1MAPTLMNAHPD
SCHEMBL12161433 0.81 P2RY12 (0.54) P2RY12PPARGTP53NOD1MAPT
SCHEMBL14228576 0.79 P2RY12 (0.49) P2RY12PPARGTP53NOD1MAPT
SCHEMBL14228578 0.79 P2RY12 (0.53) P2RY12PPARGTP53NOD1MAPT
SCHEMBL9922360 0.78 P2RY12 (0.45) P2RY12PPARGTP53NOD1MAPT
SCHEMBL13638511 0.78 P2RY12 (0.45) P2RY12PPARGTP53NOD1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed